Takeda Pharmaceutical Co Ltd

Common Name
Takeda Pharmaceutical
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
47,455
Ticker
4502
Exchange
TOKYO STOCK EXCHANGE
Description
Takeda Pharmaceutical Co., Ltd. is a leading global biopharmaceutical company headquartered in Japan. Its primary purpose is to discover, develop, and deliver innovative medicines that improve patient...

Takeda Pharmaceutical Waste Data Preview

In 2023, Takeda Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Takeda Pharmaceutical’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Takeda Pharmaceutical generated a total of 98,520 metric tonnes of waste.

Of this amount, 47.77% of Takeda Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 52.23% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Takeda Pharmaceutical’s Hazardous vs Non-Hazardous Waste Over Time

2020202120222023025 k50 k75 k100 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Takeda Pharmaceutical reduced the environmental impact of its waste?

Since 2020, Takeda Pharmaceutical's total waste generation increased by 13.24%, including a 15.21% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, the share of hazardous waste decreased by 3.8%, yet rose by 8.89% in 2023, potentially signaling operational variability, temporary setbacks, or less effective hazardous waste mitigation in the short term.

Overall, Takeda Pharmaceutical's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

Want Full Access to Takeda Pharmaceutical's Waste Management Dataset?
Sign Up